Challenges of Glycemic Control in People With Diabetes and Advanced Kidney Disease and the Potential of Automated Insulin Delivery

被引：1
|
作者：
Lu, Jean C. [1 ,2 ,3 ]
Lee, Petrova [4 ]
Ierino, Francesco [1 ,4 ,5 ]
MacIsaac, Richard J. [1 ,2 ,3 ]
Ekinci, Elif [3 ,6 ,7 ]
O'Neal, David [1 ,2 ,3 ]
机构：
[1] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic, Australia
[2] St Vincents Hosp Melbourne, Dept Endocrinol & Diabet, Fitzroy, Vic, Australia
[3] Australian Ctr Accelerating Diabet Innovat, Univ Melbourne, Parkville, Vic, Australia
[4] St Vincents Hosp Melbourne, Dept Nephrol, Fitzroy, Vic, Australia
[5] St Vincents Inst Med Res, Fitzroy, Vic, Australia
[6] Dept Endocrinol & Diabet, Austin, Vic, Australia
[7] Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic, Australia
来源：
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2024年 / 18卷 / 06期
基金：
英国医学研究理事会;
关键词：
diabetes; automated insulin delivery; insulin pump; chronic kidney disease; dialysis; artificial pancreas; HEMODIALYSIS-INDUCED HYPOGLYCEMIA; HYBRID CLOSED-LOOP; PERITONEAL-DIALYSIS; COGNITIVE FUNCTION; GLUCOSE; IMPACT; METABOLISM; RESISTANCE; SURVIVAL; MELLITUS;
D O I：
10.1177/19322968231174040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage kidney disease in the world. It is known that maintaining optimal glycemic control can slow the progression of CKD. However, the failing kidney impacts glucose and insulin metabolism and contributes to increased glucose variability. Conventional methods of insulin delivery are not well equipped to adapt to this increased glycemic lability. Automated insulin delivery (AID) has been established as an effective treatment in patients with type 1 diabetes mellitus, and there is emerging evidence for their use in type 2 diabetes mellitus. However, few studies have examined their role in diabetes with concurrent advanced CKD. We discuss the potential benefits and challenges of AID use in patients with diabetes and advanced CKD, including those on dialysis.
引用
收藏
页码：1500 / 1508
页数：9
相关论文
共 50 条
  • [21] Glycemic control and outcomes in people with diabetes and CKD
    Zoungas, Sophia
    Chalmers, John
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (03) : 133 - 134
  • [22] Glycemic control and outcomes in people with diabetes and CKD
    Sophia Zoungas
    John Chalmers
    Nature Reviews Nephrology, 2012, 8 : 133 - 134
  • [23] Insulin Delivery Method and Admission for Glycemic Control in Pregnant Women with Type 1 Diabetes Mellitus
    Sperling, Jeffrey D.
    Maggio, Lindsay
    Has, Phinnara
    Daley, Julie
    Coustan, Donald R.
    Werner, Erika F.
    AMERICAN JOURNAL OF PERINATOLOGY, 2018, 35 (03) : 209 - 214
  • [24] The Effect of a Closed-Loop Insulin Delivery System on Glycemic Control in Type 1 Diabetes
    Koutsovasilis, Anastasios
    Sotiropoulos, Alexios
    Antoniou, Anastasia
    Kordinas, Vasilios
    Papadaki, Despina
    Peppas, Theodoros
    DIABETES, 2019, 68
  • [25] Strengths and Challenges of Closed-Loop Insulin Delivery During Exercise in People With Type 1 Diabetes: Potential Future Directions
    Paldus, Barbora
    Morrison, Dale
    Lee, Melissa
    Zaharieva, Dessi P.
    Riddell, Michael C.
    O'Neal, David N.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, 17 (04): : 1077 - 1084
  • [26] Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients
    Romero, Patricia Enes
    Guemes, Maria
    Guijo, Blanca
    Martos-Moreno, Gabriel a.
    Roman, Jesus Pozo
    Argente, Jesus
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (10): : 436 - 446
  • [27] Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 Diabetes
    Ortiz-Zuniga, Angel
    Simo-Servat, Olga
    Amigo, Judit
    Sanchez, Monica
    Morer, Carla
    Franch-Nadal, Josep
    Mayor, Regina
    Snel, Tim
    Simo, Rafael
    Hernandez, Cristina
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [28] Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease
    Agarwal, Shailesh
    Gillis, Laura
    Wilkie, Martin
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (01): : 139 - 146
  • [29] Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
    Collyns, Olivia J.
    Meier, Renee A.
    Betts, Zara L.
    Chan, Denis S. H.
    Frampton, Chris
    Frewen, Carla M.
    Hewapathirana, Niranjala M.
    Jones, Shirley D.
    Roy, Anirban
    Grosman, Benyamin
    Kurtz, Natalie
    Shin, John
    Vigersky, Robert A.
    Wheeler, Benjamin J.
    de Bock, Martin I.
    DIABETES CARE, 2021, 44 (04) : 969 - 975
  • [30] Improved Glycemic Outcomes with Medtronic Minimed Advanced Hybrid Closed-Loop Delivery: Results from a Randomized Crossover Trial Comparing Automated Insulin Delivery with Predictive Low Glucose Suspend in People with Type 1 Diabetes
    Collyns, Olivia
    Meier, Renee
    Betts, Zara
    Chan, Dennis
    Frampton, Chris
    Frewen, Carla M.
    Grosman, Benyamin
    Hewapathirana, Niranjala
    Jones, Shirley
    Kurtz, Natalie
    Roy, Anirban
    Shin, John
    Vigersky, Robert
    Wheeler, Benjamin J.
    De Bock, Martin
    DIABETES, 2020, 69
12345